Michel Therin, DVM, PhD

Michel Therin, DVM, PhD, has a wealth of experience in defining and implementing Medtech deployment strategies worldwide.
Formerly President of Siemens Healthineers’ Advanced Therapies division, he defined and steered the development strategy for the interventional imaging business, focusing on oncology, neuro logy, and cardiovascular care, and played an active role in the acquisition of Corindus and Varian for a total of almost 18 billion euros.
He also spent twelve years at Medtronic as Global Vice President & General Manager, responsible for the development and marketing of innovative devices for general surgery.
Prior to this, at Floreane Medical Implants as Vice President Research & Development and General Manager for 9 years, Michel Therin invented, developed, and launched numerous breakthrough innovations in the field of abdominal and pelvic reconstruction which rapidly established themselves on the international market, leading to the company’s acquisition by Tyco Healthcare in 2006.
Since 2022 and 2023 respectively, Michel Therin has also been Chairman of the Board of Ganymed robotics ( https://www.ganymedrobotics.com ) and Affluent Medical https://www.affluentmedical.com ).
Michel Therin holds a double doctorate in veterinary medicine (École Nationale Vétérinaire de Maison Alfort) and biomedical engineering (Paris XIII). He is the author of numerous patents and publications
and has been a speaker at over 100 international medical congresses.